Associated Papers
Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients.
Han N et al.
European Journal of Clinical Pharmacology, 2014
Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers.
Guo D et al.
European Journal of Clinical Pharmacology, 2013
Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population.
Ménard V et al.
Human Mutation, 2009
Three novel single nucleotide polymorphisms of UGT1A9 in a Thai population.
Korprasertthaworn P et al.
Drug Metabolism and Pharmacokinetics, 2009
Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population.
Yea SS et al.
Therapeutic Drug Monitoring, 2008
Regulatory polymorphisms and their contribution to interindividual differences in the expression of enzymes influencing drug and toxicant disposition.
Hines RN et al.
Drug Metabolism Reviews, 2008
Lack of association between common polymorphisms in UGT1A9 and gene expression and activity.
Ramírez J et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2007
Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver.
Girard H et al.
Pharmacogenetics, 2004
Influence of UDP-Glucuronosyltransferase Polymorphisms on Mycophenolic Acid Metabolism in Renal Transplant Patients.
Xu C et al.
Transplantation Proceedings, 0
Select a paper to view details